Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 13, 2024Open Access

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies

View Full Paper
Ask AI
Bookmark
Share

Authors

SZSerena ZanottaIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"DGDomenico GalatiIstituto Nazionale Tumori IRCCS "Fondazione G. Pascale"RFRosaria De FilippiUniversity of Naples Federico II

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zanotta et al. (2024) studied this question.

synapsesocial.com/papers/68e64d72b6db6435875de361https://doi.org/10.20944/preprints202406.0880.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dendritic Cells in Cancer Immunology and Immunotherapy2024 · 131 citations
  2. 2Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges2026 · 3 citations
  3. 3Research Progress and Clinical Prospects of Dendritic Cell Vaccines in Breast Cancer Immunotherapy2025
  4. 4Engineered potent DC vaccine enables closer DC-T cell contact to trigger personalized antitumor immunity2025
  5. 5Redefining Dendritic Cell Vaccines: Synergistically Co‐priming DC and B Cells With Nanoparticles Loading Whole Cell Antigens Maximizes the Efficacy of DC Vaccines2026 · 2 citations